Target intelligence / Profile preview

Novel transcript, antisense to SNX27

Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

ENSG00000250734 corresponds to a long non-coding RNA (lncRNA) described as "novel transcript, antisense to SNX27." It is transcribed from the opposite strand of the SNX27 gene locus. Antisense lncRNAs like this are widespread in the genome and have roles in regulating the expression of their sense counterpart genes through several mechanisms including chromatin modification, transcriptional interference, and stabilization or degradation of sense transcripts. There is currently no evidence that this transcript encodes a protein or functions as a canonical drug target, receptor, or enzyme[5][3][6]. Its specific functional role and relevance to disease remain uncharacterized, though in general, antisense lncRNAs can modulate gene expression and contribute to regulatory complexity in the genome. This entry refers to a non-coding RNA with regulatory potential rather than a classical therapeutic target or protein receptor[5][3][6]. No drugs, disease associations, or biomarker roles are currently assigned specifically to this transcript.

Other names
Antisense to SNX27ENSG00000250734
02

Mechanism of action

Mechanisms known for antisense lncRNAs in general include transcriptional interference, RNA masking, RNA-DNA or RNA-RNA interaction, chromatin modification, regulation of RNA stability, but none specifically tied to this transcript

03

Biological functions

Regulation of transcriptionRNA-mediated chromatin modificationpost-transcriptional regulationother regulatory RNA functions
04

Disease associations

Other (no proven direct link to disease; some antisense RNAs have been implicated in gene regulation and disease in other contexts, but no specific disease association is reported for this transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to SNX27.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to SNX27.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call